Generics NewsLatest News On Generics Bristol Myers Squibb Unveils Cost-Cutting Plans and Beats Q4 Earnings Expectations2/6/2025 8:15 AM Teva Pharmaceuticals: A Dip Buying Opportunity?2/5/2025 1:26 AM Patients Before Monopolies Act: A Game Changer for Patients, Pharmacists, and Prices?1/24/2025 2:54 PM How to Start a Dialogue About Obesity With Patients1/21/2025 4:04 PM Change Makers: Richard Francis on the Pillars of Innovation and Growth1/10/2025 5:07 PM FDA Ends Shortage of Obesity Drugs, Phased Out Generics12/20/2024 1:25 AM ‘Urgent Need’ to Examine Anti-Seizure Medication Pricing12/13/2024 8:31 AM HIV ‘Game-Changer’ Drug: Is Eastern Europe Missing Out?12/4/2024 4:36 PM Expert Discusses the ‘Four Pillars of Acne Pathogenesis’12/3/2024 10:10 AM Costs of Common Neurologic Meds Continue to Rise11/7/2024 8:19 AM Germany’s Medication Supply Issues Persist Despite New Law11/6/2024 6:28 AM MS Drugmaker Fined €462.6 Million for Disparaging Rival11/1/2024 9:38 AM Generic Medicine OKd by Europe for Thrombocytopenia With HCV10/18/2024 11:05 AM To Choose the Best First-line Drug for CML, Consider Efficacy and Cost9/5/2024 11:19 PM US Allows Increased Production Of Takeda's ADHD Drug to Address Shortage9/4/2024 9:19 AM US Will Still Pay At Least Twice as Much After Negotiating Drug Prices9/3/2024 9:35 AM Fed Worker Health Plans Ban Maximizers and Copay Accumulators: Why Not for the Rest of the US?8/6/2024 12:41 PM Why Millions Are Trying FDA-Authorized Alternatives7/24/2024 12:22 AM No HIV Infections After Twice-a-Year PREP7/5/2024 5:57 AM Cancer Drug Shortages Continue in the US, Survey Finds6/26/2024 11:38 PM
